Lv4
600 积分 2024-11-27 加入
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
5天前
已完结
Glypican-3 Expression in Primary and Recurrent Ovarian Carcinomas
12天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
16天前
已完结
Section 8: Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes
3个月前
已关闭
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
3个月前
已完结
Anovel anti-B7-H3 nanobody and its DM1 conjugate with marked anti-tumor activity against esophageal squamous cell carcinoma
4个月前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
4个月前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
5个月前
已完结
皖公网安备34019202002308
